Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 547

1.
2.
3.

Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents in ST elevation myocardial infarction: findings from the Guthrie Health Off-label Stent (GHOST) Registry.

Sattur S, Orshaw P, Boura J, Harjai KJ.

J Interv Cardiol. 2012 Apr;25(2):118-25. doi: 10.1111/j.1540-8183.2011.00703.x. Epub 2012 Feb 10.

PMID:
22324820
4.

Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study).

Harjai KJ, Orshaw P, Shenoy C, Acharji S, Sporn D, Aboufares A, Stapleton D.

J Interv Cardiol. 2008 Aug;21(4):315-24. doi: 10.1111/j.1540-8183.2008.00380.x. Erratum in: J Interv Cardiol. 2008 Oct;21(5):441.

PMID:
18754967
5.

Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry.

Campo G, Saia F, Percoco G, Manari A, Santarelli A, Vignali L, Varani E, Benassi A, Sangiorgio P, Tarantino F, Magnavacchi P, De Palma R, Guastaroba P, Marzocchi A.

Int J Cardiol. 2010 Apr 15;140(2):154-60. doi: 10.1016/j.ijcard.2008.11.021. Epub 2008 Dec 3.

PMID:
19056134
7.

Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.

Jensen LO, Maeng M, Thayssen P, Kaltoft A, Tilsted HH, Bøttcher M, Lassen JF, Hansen KN, Krusell LR, Rasmussen K, Pedersen KE, Pedersen L, Paaske Johnsen S, Sørensen HT, Thuesen L.

Circ Cardiovasc Interv. 2008 Dec;1(3):176-84. doi: 10.1161/CIRCINTERVENTIONS.108.794578.

8.

Comparison of drug-eluting stents with bare metal stents implantation for the treatment of acute ST-elevation myocardial infarction: 2-year clinical outcomes from single-center registry.

Li Y, Han YL, Zhang QY, Guan SY, Wang XZ, Jing QM, Ma YY, Wang G, Wang B, Deng J.

Chin Med J (Engl). 2011 Mar;124(6):825-30.

PMID:
21518587
9.

Long-term efficacy and safety of drug-eluting stent implantation for patients with multiple coronary chronic total occlusions.

Zhang J, Han YL, Li Y, Wang SL, Jing QM, Wang XZ, Ma YY, Luan B, Wang G, Wang B.

Chin Med J (Engl). 2010 Apr 5;123(7):789-93.

PMID:
20497665
10.

Drug-eluting stents in patients with chronic kidney disease: a prospective registry study.

Shenoy C, Boura J, Orshaw P, Harjai KJ.

PLoS One. 2010 Nov 29;5(11):e15070. doi: 10.1371/journal.pone.0015070.

11.

Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions.

Han YL, Zhang J, Li Y, Wang SL, Jing QM, Yi XH, Ma YY, Luan B, Wang G, Wang B.

Chin Med J (Engl). 2009 Mar 20;122(6):643-7.

PMID:
19323927
12.

Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.

Park DW, Kim YH, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Kim JJ, Choo SJ, Chung CH, Lee JW, Park SW, Park SJ.

J Am Coll Cardiol. 2010 Oct 19;56(17):1366-75. doi: 10.1016/j.jacc.2010.03.097.

13.

Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry.

Harjai KJ, Kondareddy S, Pinkosky B, Harjai N, Orshaw P, Boura J.

J Interv Cardiol. 2013 Apr;26(2):153-62. doi: 10.1111/j.1540-8183.2013.12016.x. Epub 2013 Jan 31.

PMID:
23363439
15.

Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.

Slottow TL, Steinberg DH, Roy P, Javaid A, Buch AN, Okabe T, Xue Z, Smith K, Torguson R, Pichard AD, Satler LF, Suddath WO, Kent KM, Waksman R.

Cardiovasc Revasc Med. 2008 Jan-Mar;9(1):24-8. doi: 10.1016/j.carrev.2007.06.002.

PMID:
18206634
16.

Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).

Hamirani YS, Jibrin I, Abraham D, Merriman B, Wenz C, Bahr RD.

Crit Pathw Cardiol. 2008 Dec;7(4):232-8. doi: 10.1097/HPC.0b013e3181805e0b.

PMID:
19050419
17.

Comparison of late (3-year) registry data outcomes using bare metal versus drug-eluting stents for treating ST-segment elevation acute myocardial infarctions.

Assali A, Vaduganathan M, Vaknin-Assa H, Lev EI, Brosh D, Teplitsky I, Bental T, Battler A, Kornowski R.

Am J Cardiol. 2012 Jun 1;109(11):1563-8. doi: 10.1016/j.amjcard.2012.01.378. Epub 2012 Mar 20.

PMID:
22440117
18.
19.

Comparison of drug-eluting stents to bare-metal stents in ST-elevation myocardial infarction in long-term follow-up.

Kübler P, Jankowska EA, Ferenc M, Ponikowski P, Banasiak W, Reczuch K.

Kardiol Pol. 2013;71(1):25-31.

20.

Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).

Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.

JACC Cardiovasc Interv. 2013 Jun;6(6):548-53. doi: 10.1016/j.jcin.2012.12.129. Epub 2013 May 15.

Supplemental Content

Support Center